{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:33:40Z","timestamp":1782887620626,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["No.YCBZ2025110"],"award-info":[{"award-number":["No.YCBZ2025110"]}]},{"name":"The National Natural Science Foundation of Guangxi","award":["No.2023GXNSFBA026164"],"award-info":[{"award-number":["No.2023GXNSFBA026164"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82060430"],"award-info":[{"award-number":["No.82060430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Guangxi Key Research and Development Project","award":["No.AB24010149"],"award-info":[{"award-number":["No.AB24010149"]}]},{"name":"The Guangxi Clinical Research Center for Enhanced Recovery after Surgery, Guangxi Science and Technology Base and Talent Project","award":["No.AD19245196"],"award-info":[{"award-number":["No.AD19245196"]}]},{"name":"The Guangxi key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer","award":["No.YYZS2020003"],"award-info":[{"award-number":["No.YYZS2020003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14519-9","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:18:54Z","timestamp":1751354334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker"],"prefix":"10.1186","volume":"25","author":[{"given":"Jian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"14519_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"14519_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"14519_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccell.2020.05.021","volume":"38","author":"S Srivastava","year":"2020","unstructured":"Srivastava S, Hanash S. Pan-cancer early detection: hype or hope? Cancer Cell. 2020;38(1):23\u20134.","journal-title":"Cancer Cell"},{"issue":"3","key":"14519_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"1","key":"14519_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","volume":"18","author":"A Glaviano","year":"2025","unstructured":"Glaviano A, Lau HSH, Carter LM, et al. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition [J]. J Hematol Oncol. 2025;18(1):6.","journal-title":"J Hematol Oncol."},{"issue":"1","key":"14519_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","volume":"19","author":"L Kraehenbuehl","year":"2022","unstructured":"Kraehenbuehl L, Weng C-H, Eghbali S, et al. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways [J]. Nat Rev Clin Oncol. 2022;19(1):37\u201350.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"14519_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.7150\/thno.105276","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang H, Zhou F, Qin W, et al. Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies [J]. Theranostics. 2025;15(6):2159\u201384.","journal-title":"Theranostics"},{"issue":"2","key":"14519_CR8","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye B, Fan J, Xue L, et al. iMLGAM: integrated machine learning and genetic algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. Imeta. 2025;4(2):e70011.","journal-title":"Imeta"},{"issue":"1","key":"14519_CR9","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1002\/biof.2142","volume":"51","author":"B Ye","year":"2025","unstructured":"Ye B, Jiang A, Liang F, et al. Navigating the immune landscape with plasma cells: a pan-cancer signature for precision immunotherapy. BioFactors. 2025;51(1):e2142.","journal-title":"BioFactors"},{"key":"14519_CR10","doi-asserted-by":"publisher","first-page":"101865","DOI":"10.1016\/j.tranon.2023.101865","volume":"40","author":"W Sun","year":"2024","unstructured":"Sun W, Zhang P, Ye B, et al. Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma. Transl Oncol. 2024;40: 101865.","journal-title":"Transl Oncol"},{"issue":"8","key":"14519_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nn.2160","volume":"11","author":"S Sato","year":"2008","unstructured":"Sato S, Omori Y, Katoh K, et al. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci. 2008;11(8):923\u201331.","journal-title":"Nat Neurosci"},{"issue":"41","key":"14519_CR12","doi-asserted-by":"publisher","first-page":"31208","DOI":"10.1074\/jbc.M110.116343","volume":"285","author":"M Kanagawa","year":"2010","unstructured":"Kanagawa M, Omori Y, Sato S, et al. Post-translational maturation of dystroglycan is necessary for pikachurin binding and ribbon synaptic localization. J Biol Chem. 2010;285(41):31208\u201316.","journal-title":"J Biol Chem"},{"issue":"795","key":"14519_CR13","doi-asserted-by":"publisher","first-page":"eadd9539","DOI":"10.1126\/scisignal.add9539","volume":"16","author":"DN Patil","year":"2023","unstructured":"Patil DN, Pantalone S, Cao Y, et al. Structure of the photoreceptor synaptic assembly of the extracellular matrix protein pikachurin with the orphan receptor GPR179. Sci Signal. 2023;16(795): eadd9539.","journal-title":"Sci Signal"},{"issue":"1","key":"14519_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2010.11.056","volume":"489","author":"H Hu","year":"2011","unstructured":"Hu H, Li J, Zhang Z, et al. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression. Neurosci Lett. 2011;489(1):10\u20135.","journal-title":"Neurosci Lett"},{"issue":"5","key":"14519_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3892\/ijmm.2017.2927","volume":"39","author":"Y Yamada","year":"2017","unstructured":"Yamada Y, Sakuma J, Takeuchi I, et al. Identification of EGFLAM, SPATC1L and RNASE13 as novel susceptibility loci for aortic aneurysm in Japanese individuals by exome-wide association studies [J]. Int J Mol Med. 2017;39(5):1091\u2013100.","journal-title":"Int J Mol Med"},{"key":"14519_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12885-016-2371-5","volume":"16","author":"M Abe","year":"2016","unstructured":"Abe M, Yamashita S, Mori Y, et al. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes [J]. BMC Cancer. 2016;16:350.","journal-title":"BMC Cancer"},{"issue":"3","key":"14519_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3233\/CBM-181740","volume":"24","author":"J Chen","year":"2019","unstructured":"Chen J, Zhang J, Hong L, et al. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma [J]. Cancer Biomark. 2019;24(3):343\u201350.","journal-title":"Cancer Biomark"},{"issue":"1","key":"14519_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40537-022-00643-x","volume":"9","author":"C Wu","year":"2022","unstructured":"Wu C, Qin C, Long W, et al. Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development [J]. J Big Data. 2022;9(1):92.","journal-title":"J Big Data"},{"key":"14519_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112896","author":"Y Lu","year":"2023","unstructured":"Lu Y, Huo H, Liang F, et al. Role of pericytes in cardiomyopathy-associated myocardial infarction revealed by multiple single-cell sequencing analysis. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11112896.","journal-title":"Biomedicines"},{"key":"14519_CR20","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks [J]. Front Immunol. 2023;14:1212476.","journal-title":"Front Immunol"},{"key":"14519_CR21","doi-asserted-by":"publisher","first-page":"1295693","DOI":"10.3389\/fimmu.2024.1295693","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Guo Y, Yang Y, et al. Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation [J]. Front Immunol. 2024;15:1295693.","journal-title":"Front Immunol"},{"issue":"Pt 3","key":"14519_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semcancer.2022.03.014","volume":"86","author":"S Gaikwad","year":"2022","unstructured":"Gaikwad S, Agrawal MY, Kaushik I, et al. Immune checkpoint proteins: signaling mechanisms and molecular interactions in cancer immunotherapy. Semin Cancer Biol. 2022;86(Pt 3):137\u201350.","journal-title":"Semin Cancer Biol"},{"key":"14519_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.07.001","author":"LA Donehower","year":"2019","unstructured":"Donehower LA, Soussi T, Korkut A, et al. Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas. Cell Rep. 2019. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.001.","journal-title":"Cell Rep"},{"issue":"7924","key":"14519_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41586-022-05082-5","volume":"608","author":"T Baslan","year":"2022","unstructured":"Baslan T, Morris JP, Zhao Z, et al. Ordered and deterministic cancer genome evolution after p53 loss [J]. Nature. 2022;608(7924):795\u2013802.","journal-title":"Nature"},{"issue":"1","key":"14519_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-023-00502-8","volume":"11","author":"M Chen","year":"2023","unstructured":"Chen M, Jiang J, Hou J. Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications [J]. Biomark Res. 2023;11(1):55.","journal-title":"Biomark Res"},{"issue":"3","key":"14519_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"14519_CR27","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s43032-022-00981-4","volume":"29","author":"T-D Chuang","year":"2022","unstructured":"Chuang T-D, Quintanilla D, Boos D, et al. Differential expression of super-enhancer-associated long non-coding RNAs in uterine leiomyomas [J]. Reprod Sci. 2022;29(10):2960\u201376.","journal-title":"Reprod Sci"},{"issue":"5","key":"14519_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1101\/gr.197194.115","volume":"26","author":"RE Bell","year":"2016","unstructured":"Bell RE, Golan T, Sheinboim D, et al. Enhancer methylation dynamics contribute to cancer plasticity and patient mortality [J]. Genome Res. 2016;26(5):601\u201311.","journal-title":"Genome Res"},{"issue":"5","key":"14519_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Weng H, et al. RNA N6-methyladenosine modification in cancers: current status and perspectives [J]. Cell Res. 2018;28(5):507\u201317.","journal-title":"Cell Res"},{"key":"14519_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126744","author":"Y Li","year":"2024","unstructured":"Li Y, Zhu R, Jin J, et al. Exploring the role of clustered mutations in carcinogenesis and their potential clinical implications in cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25126744.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"14519_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molmed.2023.03.007","volume":"29","author":"D Ostroverkhova","year":"2023","unstructured":"Ostroverkhova D, Przytycka TM, Panchenko AR. Cancer driver mutations: predictions and reality [J]. Trends Mol Med. 2023;29(7):554\u201366.","journal-title":"Trends Mol Med"},{"issue":"2","key":"14519_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim DL, Goodman A, de Melo GD, et al. The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker [J]. Cancer Cell. 2021;39(2):154\u201373.","journal-title":"Cancer Cell"},{"issue":"1","key":"14519_CR33","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri M, Mehnert J, Silk AW, et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 2022;7(1): 100336.","journal-title":"ESMO Open"},{"issue":"1","key":"14519_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu T, Dai L-J, Wu S-Y, et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response [J]. J Hematol Oncol. 2021;14(1):98.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"14519_CR35","first-page":"7331","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang J, Feng J, Chen X, et al. Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer. Aging (Albany NY). 2024;16(8):7331\u201356.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"14519_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12967-024-05628-3","volume":"22","author":"H Yang","year":"2024","unstructured":"Yang H, Gou X, Feng C, et al. Overall survival prediction of gastric cancer using the gene signature of CT-detected extramural venous invasion combined with M2 macrophages infiltration. J Transl Med. 2024;22(1):829.","journal-title":"J Transl Med"},{"issue":"1","key":"14519_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"W-L Guan","year":"2023","unstructured":"Guan W-L, He Y, Xu R-H. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1): 57.","journal-title":"J Hematol Oncol"},{"key":"14519_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063042","author":"R Ahmed","year":"2022","unstructured":"Ahmed R, Zaman T, Chowdhury F, et al. Single-cell RNA sequencing with spatial transcriptomics of cancer tissues. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23063042.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"14519_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"1","key":"14519_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","volume":"22","author":"L Pei","year":"2023","unstructured":"Pei L, Liu Y, Liu L, et al. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer. 2023;22(1):29.","journal-title":"Mol Cancer"},{"key":"14519_CR41","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.intimp.2024.112196","volume":"134","author":"H Chen","year":"2024","unstructured":"Chen H, Liu S, Wu S, et al. GSG2 promotes progression of human endometrial cancer by regulating PD-1\/PD-L1 expression via PI3K-AKT pathway. Int Immunopharmacol. 2024;134: 112196.","journal-title":"Int Immunopharmacol"},{"issue":"15","key":"14519_CR42","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-22-3023","volume":"83","author":"F Exposito","year":"2023","unstructured":"Exposito F, Redrado M, Houry M, et al. Pten loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells [J]. Cancer Res. 2023;83(15):2513\u201326.","journal-title":"Cancer Res"},{"issue":"8","key":"14519_CR43","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","volume":"4","author":"D Brina","year":"2023","unstructured":"Brina D, Ponzoni A, Troiani M, et al. The Akt\/mTOR and MNK\/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells [J]. Nat Cancer. 2023;4(8):1102\u201321.","journal-title":"Nat Cancer"},{"issue":"13","key":"14519_CR44","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1074\/jbc.M112.432005","volume":"288","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu F, Mao F, et al. Interaction with cyclin H\/cyclin-dependent kinase 7 (CCNH\/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration [J]. J Biol Chem. 2013;288(13):9028\u201334.","journal-title":"J Biol Chem"},{"issue":"2","key":"14519_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/neuonc\/nou151","volume":"17","author":"J Lan","year":"2015","unstructured":"Lan J, Guo P, Lin Y, et al. Role of glycosyltransferase PomGnT1 in glioblastoma progression. Neuro Oncol. 2015;17(2):211\u201322.","journal-title":"Neuro Oncol"},{"key":"14519_CR46","doi-asserted-by":"publisher","first-page":"782699","DOI":"10.3389\/fgene.2021.782699","volume":"12","author":"S Nersisyan","year":"2021","unstructured":"Nersisyan S, Novosad V, Engibaryan N, et al. Ecm-receptor regulatory network and its prognostic role in colorectal cancer. Front Genet. 2021;12:782699.","journal-title":"Front Genet"},{"key":"14519_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.04.052","author":"P Zhang","year":"2019","unstructured":"Zhang P, Yang M, Zhang Y, et al. Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2019. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.052.","journal-title":"Cell Rep"},{"issue":"23","key":"14519_CR48","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-21-0792","volume":"27","author":"HY Jeong","year":"2021","unstructured":"Jeong HY, Ham I-H, Lee SH, et al. Spatially distinct reprogramming of the tumor microenvironment based on tumor invasion in diffuse-type gastric cancers. Clin Cancer Res. 2021;27(23):6529\u201342.","journal-title":"Clin Cancer Res"},{"issue":"D1","key":"14519_CR49","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment [J]. Nucleic Acids Res. 2021;49(D1):D1420\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"14519_CR50","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"14519_CR51","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 2022;1(3):e36.","journal-title":"Imeta"},{"issue":"W1","key":"14519_CR52","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"14519_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.02.052","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.","journal-title":"Cell"},{"issue":"5","key":"14519_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"key":"14519_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, et al. Ualcan: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"D1","key":"14519_CR56","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, et al. Linkedomics: analyzing multi-omics data within and across 32 cancer types [J]. Nucleic Acids Res. 2018;46(D1):D956\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"14519_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"14519_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection [J]. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"D1","key":"14519_CR59","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest [J]. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14519-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:04:07Z","timestamp":1751357047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14519-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14519"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14519-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The First Affiliated Hospital of Guangxi Medical University medical ethics committee granted ethical approval for this study (approval number 2024-E766-01), all methods were carried out in accordance with the relevant ethical guidelines and regulations of the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1109"}}